Dividend Growth Forum
My portfolio update: - Printable Version

+- Dividend Growth Forum (http://DividendGrowthForum.com)
+-- Forum: Dividend Growth Investing (http://DividendGrowthForum.com/forumdisplay.php?fid=15)
+--- Forum: My Portfolio (http://DividendGrowthForum.com/forumdisplay.php?fid=14)
+--- Thread: My portfolio update: (/showthread.php?tid=821)

Pages: 1 2


RE: My portfolio update: - EricL - 09-21-2016

Curious as to why you sold MSFT and MCD, was it simply to re-weight the portfolio a bit?

I think FLO was a good value here. There are some questions about the business and the pending lawsuit, but in the long run I think it will continue to be a good stock to own. Also hard to go wrong with AAPL as well. I don't know what price you paid, but it has had a nice move up here in the last few weeks.

As for staples, CVS, KR, and WBA look to be the most reasonably valued from my watch list.


RE: My portfolio update: - Rasec - 09-21-2016

(09-18-2016, 05:32 PM)DividendDragon Wrote: Just posting an update on my portfolio.

New positions are;

AAPL 
FLO

BT Group
Greggs 

Weight changes are;

MCD 50% Sold at $124 
MSFT 33% Sold at $54 

Sales are;

BP

Let me know what you think.
Suggestions are welcome!

Moving forward I'm looking to add more consumer staples.
I'm not looking at tech.

Tempted by;
 
DIS but low yield and poor £ to $ exchange is putting me off (not that things are going to improve anytime soon on the exchange front)
WFG


Where did you take the screenshot on your post (positions by weight)? It looks like stockrover but I can't find that info on stock rover myself.


RE: My portfolio update: - DividendDragon - 09-22-2016

(09-21-2016, 09:43 AM)Rasec Wrote:
(09-18-2016, 05:32 PM)DividendDragon Wrote: Just posting an update on my portfolio.

New positions are;

AAPL 
FLO

BT Group
Greggs 

Weight changes are;

MCD 50% Sold at $124 
MSFT 33% Sold at $54 

Sales are;

BP

Let me know what you think.
Suggestions are welcome!

Moving forward I'm looking to add more consumer staples.
I'm not looking at tech.

Tempted by;
 
DIS but low yield and poor £ to $ exchange is putting me off (not that things are going to improve anytime soon on the exchange front)
WFG


Where did you take the screenshot on your post (positions by weight)? It looks like stockrover but I can't find that info on stock rover myself.

It's on a UK platform called 'HL'


RE: My portfolio update: - DividendDragon - 09-22-2016

(09-21-2016, 08:30 AM)EricL Wrote: Curious as to why you sold MSFT and MCD, was it simply to re-weight the portfolio a bit?

I think FLO was a good value here. There are some questions about the business and the pending lawsuit, but in the long run I think it will continue to be a good stock to own. Also hard to go wrong with AAPL as well. I don't know what price you paid, but it has had a nice move up here in the last few weeks.

As for staples, CVS, KR, and WBA look to be the most reasonably valued from my watch list.


I managed to get AAPL for $92!

I sold 50% of MCD because I felt the company became overvalued and there were opportunities elsewhere.
I sold 33% of MSFT because I bought into AAPL and wanted some balance, plus it was pushing its value.

I don't really like to hold a load of tech!

I really hadn't considered CVA or WBA, so I'll take a look for my next positions.
I already hold a UK company (LSE:NXT) That's similar to KR so I don't like adding there.

I'm wishing some consumer staples would come down, them I love!

Thanks so much for the feedback!


RE: My portfolio update: - EricL - 09-22-2016

Dr. Pepper (DPS) and Church & Dwight (CHD) are some higher growth consumer staples that have treated me quite well. However, they too are pretty expensive right now.


RE: My portfolio update: - DividendGarden - 09-23-2016

(09-22-2016, 08:08 AM)EricL Wrote: Dr. Pepper (DPS) and Church & Dwight (CHD) are some higher growth consumer staples that have treated me quite well. However, they too are pretty expensive right now.

Agreed.  I love DPS, but I can't buy it at these levels.  Not when DIS, NKE, and BF.b are are near the lower end of their 52 week averages.